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Abstract
Background: Community-acquired pneumonia (CAP) is generally considered a major cause of
morbidity and mortality in the elderly. However, population-based data are very limited and its
overall burden is unclear. This study assessed incidence and mortality from CAP among Spanish
community-dwelling elderly.
Methods: Prospective cohort study that included 11,240 individuals aged 65 years or older, who
were followed from January 2002 until April 2005. Primary endpoints were all-cause CAP
(hospitalised and outpatient) and 30-day mortality after the diagnosis. All cases were
radiographically proved and validated by checking clinical records.
Results: Incidence rate of overall CAP was 14 cases per 1,000 person-year (95% confidence
interval: 12.7 to 15.3). Incidence increased dramatically by age (9.9 in people 65–74 years vs 29.4
in people 85 years or older), and it was almost double in men than in women (19.3 vs 10.1).
Hospitalisation rate was 75.1%, with a mean length-stay of 10.4 days. Overall 30-days case-fatality
rate was 13% (15% in hospitalised and 2% in outpatient cases).
Conclusion: CAP remains as a major health problem in older adults. Incidence rates in this study
are comparable with rates described in Northern Europe and America, but they largely doubled
prior rates reported in other Southern European regions.
Background
Community-acquired pneumonia (CAP) is a relatively
frequent infectious illness which causes important mor-
bidity worldwide [1,2] The reported incidence rates of
radiographically confirmed CAP in different populations
have varied between 1.3 and 11.6 cases per 1,000 inhabit-
ant-year, [3-12] with the highest rates in older adults [13-
15].
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Nowadays, CAP cases in older adults increase as a conse-
quence of an overall increase in the elderly population
(persons aged 65 years or older) [16] In developed coun-
tries, almost one half of the total hospitalisations for
pneumonia occur in patients over 65 years and pneumo-
nia is a leading cause of death among this age group [17-
21]. However, despite the recognised importance of CAP
in the elderly, information on the epidemiology of CAP in
this age group is limited and the true burden of the disease
is not well known, considering that incidence and mortal-
ity rates in elderly populations have largely varied in dif-
ferent studies.
Incidence rates varying between 2–40 cases per 1,000 eld-
erly person-year and case-fatality rates between 7–35%
have been reported for elderly patients in Europe and
North America during the last two decades [3-5,7-15,20-
23]. However, most prior studies were conducted among
general adult populations and included only a limited
number of elderly individuals,[3,7,18,10-12] many stud-
ies focused on hospitalised patients,[4,9,15,20-23] and
few studies focused on the possible contribution of outpa-
tient cases [14,24-26] To our knowledge, only two popu-
lation-based studies specifically focused on older adults,
including hospitalised and outpatient cases of CAP, have
been published [13,14].
In this study, we have assessed the overall burden of CAP
(hospitalised and outpatient cases) in a population-based
cohort of Spanish community-dwelling elderly individu-
als followed between 2002 and 2005. In prior reports we
assessed the effectiveness of the pneumococcal vaccine in
preventing pneumonia and death in this same cohort
[27,28].
Methods
Design, setting and study population
We conducted a population-based prospective cohort
study including all community-dwelling individuals 65
years or older assigned to 8 Primary Health Care Centres
(PHCC) in the region of Tarragona, a mixed residential-
industrial urban region on the Mediterranean coast in
Catalonia, Spain. Cohort members were followed from
when the study started (January 1, 2002) until the occur-
rence of the first event, the enrolment from the PHCC
ceased, death, or until the end of the study (April 30,
2005). Mean temperatures in the study area for summer
and winter seasons through the study period were 23.2°C
(73.8°F) and 9.8°C (49.6°F), respectively.
In the Spanish Health Care System, the same as in the
study area, all persons are assigned to a PHCC, where the
General Practitioner files relevant medical details on
patients during primary care visits, and there are different
reference Hospitals according to geographical and demo-
graphic data. When the study started, the Health District
of Tarragona had 12 PHCCs with an overall assigned pop-
ulation of 134,232 all-age inhabitants. The selection of
the 8 participating PHCCs was not randomised and they
were chosen taking into account the existence of elec-
tronic clinical registries working since 1998 or before. The
other 4 PHCCs in the Health District were not included
because they had only computerised clinical records more
recently. The study cohort included all community-dwell-
ing individuals assigned to the eight participating PHCCs,
who were 65 years or older at the start of the study (an
amount of 11,240 individuals with a mean age of 74.6
[SD: 7.5] years-old at baseline) The main characteristics of
the study population are extensively described elsewhere
[27,28] The study was approved by the ethical committee
of the Catalan Health Institute and was conducted in
accordance with the general principles for observational
studies set out by this institution.
Sources of data
All participating PHCCs had an institutional database
with registries of administrative data, medical conditions
and diagnoses associated with outpatient visits coded
according to the International Classification of Diseases,
9th Revision, Clinical modification (ICD-9). This institu-
tional database and the primary care clinical records of
each cohort member were respectively used to identify
and validate cases of outpatient CAP which occurred
among cohort members during the survey. An active sur-
veillance program on CAP was established before the
study period and primary care physicians were asked to
register all cases of CAP radiographically confirmed in
their patients.
The hospital discharge diagnoses database and the clinical
medical records of the three participating reference hospi-
tals (Joan XXIII, Santa Tecla, and Pius Hospital) were used
to identify hospitalisation for CAP in cohort members
during the study period.
Outcome measure and definitions
Primary endpoints were CAP and death from CAP. Pneu-
monia was defined when a new radiological infiltrate was
identified with one major criteria (cough, expectoration,
and fever) or two minor criteria (dyspnea, pleuritic pain,
altered mental status, pulmonary consolidation on aus-
cultation, and leukocytosis) [22]. Death from pneumonia
was considered when the patient died (in-hospital or not)
within the first 30 days after the diagnosis [29,30].
Hospitalisations for CAP were identified on the basis of
the first-listed code in the Hospital discharge database
(ICD-9 codes for pneumonia: 480 to 487.0), whereas out-
patient CAPs were primary care or emergency visits with
an ICD-9 code registered for pneumonia in the PHCCsBMC Public Health 2008, 8:222 http://www.biomedcentral.com/1471-2458/8/222
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databases. All the cases of CAP (hospitalised and outpa-
tient) were radiographically confirmed and validated by
checking clinical records.
Given that PHCCs and Hospital medical records of case
patients were reviewed several weeks after the diagnosis of
CAP, the physician reviewer verified that x-ray findings
improved with treatment and excluded the possibility that
the episode was not a readmission (defined as a re-hospi-
talisation within 30 days after inpatient treatment of CAP)
or a nosocomial pneumonia (defined as a pneumonia
acquired after hospital admission at any time) [31,32].
Statistical analysis
Incidence rates of CAP were calculated as person-year,
considering that in the denominator the total persons-
time for the study period was simply the sum of the per-
son-time contributed to each individual during the study
period. Case-fatality rates were calculated by dividing the
number of cases of deaths from CAP by the absolute
number of CAP cases in each age- and sex- specific stra-
tum. Event rates were based on the first episode of CAP
occurring during the study period and they do not include
multiple events per person. Confidence intervals (CI)
were used to compare incidence and mortality rates
between the different categories and population groups.
Chi-squared and Fisher's tests were used to calculate p-val-
ues in the comparison of proportions, whereas Student's
test and one-way analysis of variance were used to com-
pare continuous variables. Statistical significance was set
at p < 0.05. The analyses were performed using Stata/SE
version 9.1 (Stata Corp.).
Results
The 11,240 cohort members were observed for a total of
33,905 person-year. Overall, 43.5% of the subjects were
male, 55.2% were aged 65–74 years and 10.5% were aged
85 years or older at baseline. Of the 11,240 cohort mem-
bers, 1,497 (13.3%) died during the 40-month study
period and 315 (2.8%) were lost patients during follow-
up. Table 1 shows study population and person-time fol-
lowed according to sex and age-groups.
A total of 380 cohort members who had a presumptive
episode of hospitalisation for CAP were identified on the
basis of the hospital discharge databases. Information on
369 (97%) of these events was available for clinical record
review, of which 355 were validated as CAP cases and 14
were excluded (nosocomial pneumonia or other diag-
noses). Furthermore, a total of 132 individuals with an
episode of presumptive outpatient pneumonia were iden-
tified according to ICD-9 pneumonia codes from emer-
gency or ambulatory visits, but only 118 cases (89%) were
included as radiologically-confirmed outpatient CAP after
review of the clinical records. This means that annual inci-
dence rates (per 1,000 elderly person-year) was 13.95 for
overall CAP (95% CI: 12.72 to 15.31), whereas incidences
were 10.47 for hospitalised CAP (95% CI: 9.42 to 11.61)
and 3.48 for outpatient CAP (95% CI: 2.88 to 4.17).
Incidence rates of overall CAP increased significantly by
age groups (9.9 in 65–74 years, 16.9 in 75–84 years and
29.4 in people 85 years or more; p < 0.001) and were
almost two-fold higher in males than in females (19.3 vs
10.1; p = 0.001).
Table 2 shows incidence rates of hospitalised and outpa-
tient CAP, according to sex and age groups. The incidence
rate was consistently higher among men than among
women, across all age groups and for both hospitalised
and outpatient CAP, although the difference was not
always statistically significant for outpatient CAP.
Overall, 75.1% of CAP episodes were hospitalised and
24.9% were managed as outpatients. Percentages of CAP
cases requiring hospitalisation were 74.3% among
patients 65–74 years, 77.7% in 75–84 years and 70.4% in
85 years or older (p = 0.429).
The mean days of hospitalisation was 10.4 days (SD:
8.02). We observed that the mean length-stay was slightly
higher in men than in women (10.8 vs 9.8; p = 0.241).
According to age groups, the means of length-stay were 11
days in people 65–74 years, 10.3 days in people 75–84
years, and 9.2 days in people 85 years or older (p = 0.332).
Table 1: Study population and person-year followed according sex and age groupsa.
Sex Number of persons (No. of person-year followed)
Age group Male Female Overall
65–74 yrs 2897 (9016) 3308 (10573) 6205 (19589)
75–84 yrs 1578 (4533) 2281 (6887) 3859 (11420)
85 yrs or more 417 (1001) 759 (1895) 1176 (2896)
Overall age groups 4892 (14550) 6348 (19355) 11240 (33905)
aAge was considered when study started on January 1, 2002.BMC Public Health 2008, 8:222 http://www.biomedcentral.com/1471-2458/8/222
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Twenty (5.6%) of 355 hospitalised CAP were admitted in
the Intensive Care Unit (ICU), with a mean stay of 10.6
days (SD: 9.9).
The mean incidence of CAP was more than two-fold
higher in winter than in summer (9.1 vs 4.1 cases per
100,000 persons-week, respectively). Figure 1 shows the
monthly distribution of incidence rates for both hospital-
ised and outpatient CAP during the study period.
As for 30-days mortality after the diagnosis, there were 60
deaths from CAP (two deaths among CAP cases managed
as outpatient, three deaths of patients in Emergency Unit
before hospitalisation, and 55 deaths among hospitalised
patients). This means that the annual mortality rate from
CAP was 177 per 100,000 elderly persons-year (95% CI:
135 to 228). Overall, 30-days case-fatality rate was 12.7%.
Mortality was only 2% for CAP cases managed as outpa-
tient, whereas it reached 15% for CAP requiring hospital-
isation (40% for patients admitted in the ICU). Case-
fatality rate did not differ significantly between sex
(13.9% in male vs 10.9% in female, p = 0.328), but
increased dramatically with increasing age (7.2% in peo-
ple 65–74 years, 13.5% in people 75–84 years and 23.5%
in people 85 years or older; p = 0.002). Table 3 shows the
different CAP case-fatality rates according to sex and age
strata.
Discussion
In the present study, we have assessed population-based
incidences and 30-days mortality of CAP among people
65 years or older in a well defined geographic area on the
Mediterranean Coast of Spain during a consecutive 40-
month study period. To our knowledge, this is the first
contemporary study to assess rates of both hospitalised
and outpatient CAP specifically focused on community-
dwelling elderly people in a European country.
Incidence of CAP in elderly people, according to monthly dis- tribution of hospitalised and outpatient cases, in the region of  Tarragona (Spain) between January 2002 and April 2005 Figure 1
Incidence of CAP in elderly people, according to 
monthly distribution of hospitalised and outpatient 
cases, in the region of Tarragona (Spain) between 
January 2002 and April 2005.
Table 2: Incidence Rates (IR) of community-acquired pneumonia (CAP), by age group and sex, during the study period.
Sex Male Female
Age group No. CAP IRa(95% CI)b No. CAP IRa(95% CI)b P-valuec
65–74 yrs
Hospitalised CAP 100 11.09 (9.04–13.47) 45 4.26 (3.11–5.69) 0.000
Outpatient CAP 27 2.99 (1.98–4.35) 23 2.18 (1.38–3.26) 0.257
All CAP 127 14.09 (11.76–16.73) 68 6.43 (5.00–8.14) 0.000
75–84 yrs 0.000
Hospitalised 90 19.85 (16.00–24.34) 60 8.71 (6.66–11.19) 0.030
Outpatient 24 5.29 (3.40–7.86) 19 2.76 (1.56–4.30) 0.000
All CAP 114 25.15 (20.80–30.13) 79 11.47 (9.10–14.27)
85 yrs or more
Hospitalised 29 28.97 (19.50–41.32) 31 16.36 (11.15–23.13) 0.234
Outpatient 10 9.99 (4.80–18.30) 15 7.92 (4.44–13.02) 0.575
All CAP 39 38.96 (27.86–52.85) 46 24.27 (17.83–32.23) 0.026
Overall age groups
Hospitalised 219 15.05 (13.14–17.16) 136 7.03 (5.90–8.30) 0.000
Outpatient 61 4.19 (3.21–5.38) 57 2.94 (2.23–3.81) 0.054
All CAP 280 19.24 (17.08–21.60) 193 9.97 (8.62–11.47) 0.000
aIncidence Rates are estimated for 1,000 person-year.
bCI denotes confidence interval
cP-values were calculated using Chi-squared test.BMC Public Health 2008, 8:222 http://www.biomedcentral.com/1471-2458/8/222
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We have found that the incidence of CAP in our popula-
tion (14 episodes per 1,000 elderly person-year) is more
than three-folds higher than incidences previously
reported in other Mediterranean regions[8,10-12] and it is
more similar to CAP incidences reported in Northern
Europe or North America for elderly population groups
[7,9,14,15].
In Europe, in those population-based studies that evalu-
ated the incidence of CAP in the general adult population,
the reported incidence rates of CAP among the subgroup
of people aged 65 years or older varied widely from 2
cases per 1,000 elderly person-year in Spanish individu-
als[10] to 24 cases per 1,000 reported among Finnish eld-
erly people [7]. In three different regions along the
Spanish Mediterranean Coast, the reported incidences of
overall CAP have ranged from 1.2 to 1.8 cases per 1,000
all-age adult population (2.3 to 3.8 cases per 1,000 among
people 65 years or older) [8,10,11] Incidence rates of 1.7
and 3.3 episodes of CAP per 1,000 person-year have been
recently reported among Italian all-age adults and elderly
individuals, respectively [12].
If we compare our results with those recently reported by
Jackson et al[14] in a population-based cohort study that
evaluated the incidence of CAP among 46,237 elderly
individuals in Washington State between 1998–2001, we
can observe similar incidence rates of CAP requiring hos-
pitalisation (10.5 per 1,000 in this study vs 11.5 per 1,000
in the Jackson's report). In contrast, the incidence of out-
patient CAP was largely higher in USA elderly than in the
present study (16.8 vs 3.5 cases per 1,000 person-year),
which probably reflects differences in the definition crite-
ria and management of outpatient CAP in both studies. In
the present study (excluding three CAP cases who died in
the emergency room before their possible hospitalisa-
tion), 15.5% of hospitalised CAP and 1.7% of outpatient
CAP died within 30 days after the diagnosis, while in Jack-
son's report these percentages were 12.5% and 0.4%
respectively. Overall, 4% of all the deaths in the cohort
during the study period occurred within 30 days after a
CAP diagnosis in this study versus 3.6% in Jackson's
report.
In this study, incidence of CAP increased dramatically
with ageing, achieving the highest rate in people aged 85
years or more, where 29 cases per 1,000 person-year were
observed. According to sex and age strata, very elderly men
are at the greatest risk considering that one episode of CAP
can be expected every year for every 25 men aged 85 years
or older. Similar trends in the incidence rates stratified by
age have been reported in most prior epidemiological
studies, considering that the frequent association between
increasing age and presence of underlying diseases
accounts for an increased morbid-mortality due to CAP in
the oldest adults [17,18,21]. It must also be noted that in
this study the 30-days case-fatality rate was three fold
higher among patients 85 years or older than in patients
65–74 years, which supports the important specific role of
age as a predictor of 30-days mortality among patients
with CAP, as the pneumonia severity score reflects [29].
In the present study, the high rate of hospital admission
may be explained by the characteristics of the study cohort
(mean age: 75 years) and the characteristics of the "Tarra-
gona region" where the study was conducted, particularly
in relation to the easy accessibility to the reference hospi-
tal so that many patients sought medical care directly
from the emergency service of the hospital rather than vis-
iting a primary care physician. Interestingly, although the
proportion of hospitalised cases was high in the present
study, the incidence rate of CAP requiring hospitalisation
resembles the rates reported in population-based studies
conducted in the USA, where figures between 10.1 and
11.5 per 1,000 elderly person-year have been reported
[9,14].
Conclusion
Our study has several strengths. Study design was popula-
tion-based, outcome measures and definitions were based
Table 3: Overall 30-days mortality from community-acquired pneumonia (CAP) in elderly subjects, according to age and sex strata.
Sex Mortality within 30-days after diagnosis of community-acquired pneumonia
Male Female
Age groups No. of events Deaths/
CAPs
Case-fatality % (95% 
CI)a
No. of events Deaths/
CAPs
Case-fatality % (95% 
CI)a
P-valueb
65–74 yrs 11/127 8.7 (4.4–14.5) 3/68 4.4 (0.9–12.4) 0.386
75–84 yrs 19/114 16.7 (10.3–24.8) 7/79 8.9 (3.6–17.4) 0.118
85 yrs or more 9/39 23.1 (11.1–39.3) 11/46 23.9 (12.6–38.8) 0.927
Overall people 39/280 13.9 (10.1–18.5) 21/193 10.9 (6.9–16.2) 0.328
aCI denotes confidence interval
bP-values were calculated, where appropriate, by Chi-squared or Fisher's tests.BMC Public Health 2008, 8:222 http://www.biomedcentral.com/1471-2458/8/222
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on defined criteria in classical studies and meta-analy-
sis[30] and all cases of CAP were radiographically con-
firmed and validated by clinical record review. However,
considering that case finding was primarily restricted to
hospitalisations or outpatient visits recorded with an ICD-
9 code 480–487 and chest-radiograph was needed to val-
idate each case, one limitation of this study could be the
possible under-identification of CAP events. This possible
problem is likely to be more important for CAP treated on
an outpatient basis than in hospitalised cases. For outpa-
tient CAP, although our study design allowed for the
inclusion of all cases of pneumonia diagnosed by primary
care physicians in the study area, it is possible that some
patients with mild symptoms were missed because they
were not referred to the hospital or the emergency unit for
evaluation, because a chest radiograph was not ordered,
or because pneumonia diagnosis code was not recorded
in the primary care clinical record. A second limitation of
this study lies in the fact that, although it includes all com-
munity dwelling elderly persons assigned to 8 different
PHCCs, overall study population includes only persons
living in a single geographic area, and it may not be pos-
sible to extrapolate the findings to the Spanish population
as a whole.
In the next few years, population-based studies focused
on the incidence and epidemiology of CAP are needed to
investigate the true burden of CAP at the beginning of the
third millennium in different settings and study popula-
tions. Specifically, considering elderly people, the burden
of CAP is highest in these subjects and the effects of cur-
rently implemented preventive measures such as smoking
cessation or pneumococcal vaccination (largely focused in
this high-risk group) should be evaluated on the basis of
actual surveillance and incidence data.
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